Opioid Dependence: Clinical Trials

6 trials for Opioid Dependence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated, 1 withdrawn. 6 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 16Completed 3, Recruiting 1, Terminated 1, Withdrawn 1

Follow Opioid Dependence: new trials by email Literature Review of Opioid Dependence trials Research Report on Opioid Dependence

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
OLP to Manage Pain in TJA: A Feasibility Study
Open Label Placebo, Patient medication as standardly prescribed - Opioid Dependence, Opioid Abuse
Early Phase 1WithdrawnUniversity of Alabama at Birmingham2023-12-012025-05-13
Measuring Acute Drug Demand in Humans
Drug A (Blinded Drug), Drug B (Blinded Drug), Drug C (Blinded Drug) - Opioid Use Disorder, Opioid Dependence
Early Phase 1RecruitingUniversity of Maryland, Baltimore752023-08-082026-06-23
Re-entry XR-NTX for Rural Individuals With Opioid Use Disorder
XR-NTX community location - Opioid Dependence
Early Phase 1CompletedMichele Staton92019-09-112023-03-27
Reducing the Abuse of Opioids in Drug Users
Oxycodone/Placebo, Oxycodone/Risperidone, Oxycodone/Ziprasidone - Opioid Abuse, Unspecified, Opioid Dependence
Early Phase 1TerminatedThe University of Texas Health Science Center at San Antonio32019-04-012022-02-15
Developing rTMS Treatment Strategies for Pain in Opiate Dependence
Real iTBS, Sham iTBS, Real cTBS - Pain, Chronic Pain
Early Phase 1CompletedMedical University of South Carolina702017-02-092020-01-06
Methadone Oxytocin Option
Oxytocin, Saline Nasal Spray - Substance Abuse, Opioid Dependence
Early Phase 1CompletedUniversity of California, San Francisco642012-05-012019-05-21

Narrower conditions

Opioid-Related Disorders (6)  ·  Chronic Pain (1)  ·  Pain (1)  ·  Substance-Related Disorders (1)

Broader conditions

Chemically-Induced Disorders (6)  ·  Mental Disorders (6)  ·  Narcotic-Related Disorders (6)  ·  Substance-Related Disorders (5)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Oxycodone (1)  ·  Oxytocin (1)  ·  Risperidone (1)  ·  suvorexant (1)  ·  vivitrol (1)  ·  ziprasidone (1)

Sponsors

Medical University of South Carolina (1)  ·  Michele Staton (1)  ·  The University of Texas Health Science Center at San Antonio (1)  ·  University of Alabama at Birmingham (1)  ·  University of California, San Francisco (1)  ·  University of Maryland, Baltimore (1)

Countries

United States (5)

Top investigators

Ameet Nagpal, MD (1)  ·  Colleen A Hanlon, PhD (1)  ·  Joshua Woolley, MD, PhD (1)  ·  Justin Strickland, PhD (1)  ·  Michele Staton, PhD (1)  ·  Sameer Naranje (1)  ·  Tapan Mehta (1)

Results publications

PMID 27137199

NIH funding

R01DA055634 (1), R34DA045856 (1)